/PRNewswire/ — Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision…
Forward-looking statements are based on Azitra, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice .
